Lazarow P B, de Duve C
J Cell Biol. 1973 Nov;59(2 Pt 1):491-506. doi: 10.1083/jcb.59.2.491.
Early events in the biosynthesis of liver catalase were studied on female rats receiving [(3)H]leucine or [(3)H]delta-aminolevulinic acid or a mixture of [(3)H]leucine with [(14)C]delta-aminolevulinic acid by intraportal injection. Catalase antigen was selectively separated from homogenates by immunoprecipitation, both without and after partial purification of the enzyme. Label from both precursors appeared first in immunoprecipitable material which was lost upon purification of catalase; the label subsequently became associated with material indistinguishable from catalase. Kinetic analysis of the results indicates that the nonpurifiable material identified by early labeling consists of two distinct biosynthetic intermediates, the first lacking heme and representing about 1.6% of the total catalase content or 13 microg/g liver, the second containing heme and representing about 0.5% of the total catalase content or 4 microg/g liver. The first intermediate migrates at the same rate as catalase upon sodium dodecyl sulfate-polyacrylamide gel electrophoresis, and therefore has a monomeric molecular weight of about 60,000.
通过门静脉注射,给雌性大鼠注射[³H]亮氨酸、[³H]δ-氨基乙酰丙酸或[³H]亮氨酸与[¹⁴C]δ-氨基乙酰丙酸的混合物,研究肝脏过氧化氢酶生物合成的早期事件。通过免疫沉淀从匀浆中选择性分离过氧化氢酶抗原,无论酶是否经过部分纯化。两种前体的标记首先出现在免疫沉淀物质中,该物质在过氧化氢酶纯化后消失;随后标记与与过氧化氢酶无法区分的物质相关联。对结果的动力学分析表明,早期标记鉴定出的不可纯化物质由两种不同的生物合成中间体组成,第一种不含血红素,约占过氧化氢酶总量的1.6%或13微克/克肝脏,第二种含血红素,约占过氧化氢酶总量的0.5%或4微克/克肝脏。在十二烷基硫酸钠-聚丙烯酰胺凝胶电泳中,第一种中间体与过氧化氢酶迁移速率相同,因此单体分子量约为60,000。